4SC's associated company Panoptes Pharma concludes license agreement with Mediolanum for compound PP-001 for inflammatory eye diseases
4SC Discovery GmbH, a subsidiary of the biotechnology company 4SC AG (Frankfurt, Prime Standard: VSC) today announced th…